The clinical classification of myocardial infarction (MI) into five types was introduced in 2007 as a component of the universal definition. A Type 5 MI was defined as a MI related to coronary artery bypass surgery. In a setting of patients undergoing elective coronary artery bypass grafting, we set out (i) to describe the pattern of multiple serial cardiac troponin I (cTnI) measurements within 72 h postoperatively and (ii) to determine the optimal cardiac troponin I cut-off value in ruling in or ruling out a Type 5 MI.
INTRODUCTION
The diagnostic criteria for myocardial infarction (MI) following coronary artery bypass grafting (CABG) have changed considerably over the last two decades [1] [2] [3] [4] . In 2007, the Type 5 MI was introduced as a part of the universal definition. A Type 5 MI was defined as a rise of cardiac biomarkers more than five times the 99th percentile of the normal upper reference limit (URL) during the first 72 h following CABG [5] . In addition, electrocardiographic changes, new angiographic findings or specified features of imaging modalities also had to be present to fulfil the Type 5 MI diagnosis. Cardiac troponin (I or T) has been emphasized as the biomarker of choice [5] . From a clinical point of view, the diagnosis of a CABG-related MI is difficult, and recently an expert consensus document has pointed out Type 5 MI as an area in need of further research [6] .
In this study, we wanted (i) to describe the pattern of multiple serial cardiac troponin I (cTnI) measurements obtained following CABG and (ii) to determine the optimal cTnI cut-off value in ruling in or ruling out a Type 5 MI.
MATERIALS AND METHODS

Study population
Between 15 September 2011 and 29 June 2012, a total of 281 patients with stable angina were screened. Inclusion criteria were two-and three-vessel disease and planned elective CABG. The exclusion criteria were single-vessel disease, concomitant valvular or maze surgery, diabetes mellitus demanding medical treatment, MI within 30 days, planned off-pump CABG, acute or subacute CABG, language barrier and dementia. Figure 1 shows the results of the screening procedure. Of the 141 eligible patients, 110 gave written informed consent. Of these, 11 were excluded for the following reasons: off-pump surgery despite planned on-pump procedure (n = 5), MI within 30 days (n = 1), subacute CABG (n = 1), not scheduled mitral valve plasty (n = 1), not scheduled maze surgery (n = 1), surgery cancelled (n = 1) and missing blood samples (n = 1). Thus, 99 of 141 (70%) eligible patients were finally enrolled.
Anaesthesia
The type of anaesthesia and doses were left to the discretion of the attending anaesthesiologist. Despite the individualized treatment, the general guidelines for surgery were induction of anaesthesia with sufentanil, propofol and cisatracurium. Patients were offered high thoracic epidural for analgesia if no contraindications were present. Anaesthesia was maintained with sevoflurane, and epidural analgesia with bupivacaine and sufentanil. If patients did not have high thoracic epidural anaesthesia, anaesthesia was maintained with sevoflurane and sufentanil.
Surgical procedure
All the patients had cardiopulmonary bypass (CPB) performed. After heparin infusion with activated clotting time >480 s, CPB was established. This was done with a two-staged venous cannulation through the right atrium, while the antegrade cardioplegia cannula and aortic cannula were placed in the ascending aorta. Bladder temperature was allowed to decline to 36°C. Pump flow was at least 2.4 l/m 2 body surface area/minute and was delivered non-pulsatile. Arterial pressures were maintained between 40 and 60 mmHg during CPB. Cardio-protection was achieved with antegrade cold blood cardioplegia. The cardioplegia concentrate was provided by the hospital pharmacy; 500 ml concentrate contained 2.7 g KCl, 796 mg potassium citrate, 98 mg citric acid, 76 mg sodium hydrogen phosphate dehydrate, 745 mg NaCl, 2.18 g trometamol and 19 g glucose monohydrate. This was diluted 1 : 4 with cold blood (4°C), thus the final potassium concentration was 18 mmol/l. This procedure was repeated every 15-20 min, depending on the surgeon. Additionally, cardioplegia was delivered through the distal venous anastomoses. Graft flow was not routinely measured.
All distal anastomoses were performed during one single period of aortic cross-clamping. Proximal anastomoses were done either in the same period of cross-clamping or with the use of an aortic side clamp, at the discretion of the individual surgeon.
Blood sampling
The first blood sample was drawn before induction of anaesthesia. Removal of the cross-clamp during surgery (time zero) defined the timing for the following samples, which were drawn 2, 4, 6, 12, 24, 48 and 72 h later. Attending physicians (cardiologists, anaesthesiologists and cardiac surgeons) had access to routine cTnI measurements, which were drawn 4 h postoperatively and at 5 a.m. on the following day. However, the attending physicians were blinded to the serial study cTnI blood sample results. Thus, the blood samples drawn in this study were not used in the diagnostic work-up and had no influence on the patient's clinical treatment. 
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Troponin analysis cTnI analyses were performed within 8 h using the Abbott c16000 (Abbott Diagnostics, Chicago, IL, USA). According to the manufacturer, this analysis has a limit of detection of 9 ng/l, the 99th percentile is 28 ng/l and the coefficient of variation is 10% at 32 ng/l. The URL at our institution is a cTnI value of 30 ng/l.
Electrocardiograms
In all patients, a 12-lead electrocardiogram (ECG) was routinely obtained preoperatively and again 24, 48 and 72 h following surgery. All ECGs were analysed for the appearance of new Q-waves or left bundle branch block. The attending physicians had access to all routine ECGs and could order more ECGs on individual basis.
Echocardiography and coronary angiography
Perioperative transoesophageal echocardiography was performed in all patients. The attending physicians ordered postoperative echocardiography or coronary angiography if there were any clinical suspicion that a patient had a postoperative complication. Patients with an uncomplicated postoperative course had no additional routine diagnostic procedures done.
Patient review
Based on patient records, including routine blood test results 4 h after arrival to the intensive care unit and at 5.a.m. the following day, a consultant cardiologist decided whether the patients fulfilled the criteria of a Type 5 MI according to the universal definition [5] . Thus, the diagnosis was based on cTnI measures, new ECG findings (Q-waves or left bundle branch block), new echocardiographic findings (reduced ejection fraction or new regional wall motion abnormality) and/or new findings on coronary angiography (occlusion in native vessels or bypass grafts). The ECGs in the diagnostic set-up were those available from clinical routine. The decision to perform additional diagnostic procedures was left to the attending physicians.
Statistical analyses
Statistics were performed using STATA version 12.1 (StataCorp LP, College Station, TX, USA) and GraphPad Prism version 6 (GraphPad Software, Inc., San Diego, CA, USA). For comparison of categorical variables, χ 2 test or Fisher's exact test were used. Fisher's exact test was used if the total number of observations in a table were <20, or if the expected number in a cell was <5 for tables with 20-40 observations. For comparison of numerical variables that were normally distributed, the Student's t-test was used. In case of a non-normally distribution, a Mann-Whitney U-test was used. Receiver operating characteristic (ROC) curves were obtained for Type 5 MI. Area under the ROC curve (ROC AUC ) was calculated and optimal cut-off points were identified by tracking the point closest to the upper left corner. Fischer et al. [7] defined the following three categories for AUCs: low accuracy (0.5-0.7), moderate accuracy (0.7-0.9) and high accuracy (>0.9). In order to be clinically relevant, we required that the AUCs were >0.8. Thus, the ROC AUC had to be >0.8. All P-values used were two-sided, and a P < 0.05 was considered statistically significant.
Ethics
The Regional Scientific Ethical Committee for Southern Denmark approved the study, and written informed consent was obtained from all participating patients.
RESULTS
Eight patients (8%) were diagnosed as having a Type 5 MI, and of these, 3 had new Q-waves or new left bundle branch block. Six of the 8 patients had new echocardiographic findings. Three patients had angiographically verified new occlusion in bypass grafts or native coronary vessels. Overall, 6 coronary angiographies and 55 transthoracic echocardiographies were performed postoperatively. The median time from the end of CABG to the diagnostic procedure that confirmed the Type 5 MI diagnosis was 10.8 h (SD 7.7). All Type 5 MIs were identified within the first 24 h following CABG. Baseline characteristics for the 99 patients included and for the subgroups of patients with and without Type 5 MI are shown in Table 1 . In total, each patient had 3.1 (SD 0.8) distal anastomoses performed. Ninety-four patients had one anastomosis performed with the left internal mammarian artery. One patient had a radial artery graft, while the remaining anastomoses were done by use of saphenous vein grafts. The right internal mammarian artery was not used in any patient. Additional perioperative data are shown in Table 2 .
Cardiac troponin I following coronary artery bypass grafting
The rise in cTnI values was steeper in patients with Type 5 MI than in those without. The median peak value for patients with Type 5 MI was 20 500 vs 7675 ng/l in patients without Type 5 MI (P = 0.01) corresponding to 683 and 255 times the URL, respectively. The median cTnI values in all study patients and in patients with and without Type 5 MI are presented in Table 3 and Fig. 2 . In the patient group as a whole, the cTnI values increased to a median of 241 ng/l, when the aortic cross-clamp was removed. This corresponds to eight times the URL. Six hours later, the median peak value in all patients was 8000 ng/l (266 times the URL). The median cTnI values in patients with Type 5 MI, compared with patients without Type 5 MI, differed for all samples drawn in the interval from 2 to 72 h after CABG, although the difference only reached the level of statistical significance from the 12 h sample and beyond.
Cardiac troponin I course and peak level
For all except 1 patient, the course of the cTnI level was monophasic. The 1 patient with a biphasic course had cTnI peak values at 6 and 24 h. The time from removal of the aortic cross-clamp to peak cTnI was longer in patients with a Type 5 MI than in patients without (P = 0.003). The median time to cTnI peak value was 12 h in patients with Type 5 MI and 6 h in patients without Type 5 MI.
Area under the receiver operating characteristic curve
In order to decide the optimal cTnI cut-off value at different sample times and at the time of the peak cTnI values, ROC curves were constructed (Fig. 3 and Table 4 ). The cut-off values were 7970 ng/l (266 times URL), 9950 ng/l (331 times URL) and 16 800 ng/l (560 times URL), considering the 12-h sample, the 24-h sample and the sample representing the individual cTnI peak value, respectively. With these cut-off cTnI values, we obtained ROC AUC of 0.86, 0.96 and 0.85, respectively. The corresponding sensitivity, specificity, positive predictive value and negative predictive value for these sample times in Type 5 MI are presented in Table 5 .
DISCUSSION
A number of earlier studies have described the course of troponin concentrations following CABG, and it appears that all patients display significant elevations postoperatively [4, [8] [9] [10] . Howeverand for obvious reasons-cohort studies addressing the Type 5 MI are few [11, 12] . In the present study, we observed median peak cTnI values in Type 5 MI patients that were nearly 700 times the upper 99th percentile of the URL. These orders of magnitude are far greater than five times the 99th percentile proposed in the 2007 universal definition [5] and 10 times the 99th percentile recommended in the recent 2012 update of the universal MI definition [13] . In the few earlier studies addressing Type 5 MI, cardiac magnetic resonance imaging (cMRI) has served as the 'gold standard'. Pegg et al. [12] proposed the optimal cut-off point for cTnI following CABG to be 165 times the URL for identifying Type 5 MI patients. In their study, the ROC AUC was 0.91 at 24 h. Despite the large difference in study designs, we found an almost identical ROC AUC (0.96) at 24 h with an optimal cut-off value of 9950 ng/l, corresponding to 332 times the URL. With a cut-off point of 9950 ng/l, the sensitivity was 0.88 and the positive predictive value was 0.35. Specificity and negative predictive values were 0.86 and 0.99, respectively. The low positive predictive value reflects that postoperative cTnI values above the defined cut-off are observed in a large proportion of both patients with and without Type 5 MI. Therefore, in clinical routine, cTnI appears to be of limited importance as a marker that can identify patients with a definite Type 5 MI. However, our data suggest that cTnI is an excellent biomarker when it comes to ruling out a Type 5 MI.
In our study, the median peak cTnI value in the 91 patients without Type 5 MI was 7675 ng/l corresponding to 255 times the URL. Based on these results and the observations by Pegg et al., the cut-off point criteria proposed by the universal definition do not appear to be useful in the identification of patients with Type 5 MI. In fact, all patients undergoing CABG demonstrate cTnI levels far above the suggested cut-off point of the universal definition, including the recent 2012 update [5, 13] . According to our study, the cTnI increase should be at least 500 times the 99th percentile of the normal reference range in order to discriminate between patients with and without Type 5 MI. As illustrated in Table 4 , the optimal peak value cut-off was 16 800 ng/l corresponding to 560 times the URL. This peak value cut-off is interesting, since the universal definition states that any observed biomarker value within 72 h following CABG, exceeding five times the URL with previously described clinical findings is diagnostic for Type 5 MI [5] . In the 2012 universal definition of MI [13] , the biomarker criterion was raised to 10 times the URL, and the time span was shortened to 48 h. Despite these definitional changes, our data suggest that both the biomarker and the time criteria would benefit from further tightening.
The incidence of Type 5 MI varies depending on the diagnostic procedures used. To our knowledge, no studies have systematically tested for all the elements that are incorporated in the universal definition. In order to do this, any patient considered should undergo serial blood sampling for cTnI, serial ECGs, imaging techniques and coronary artery angiography within 48 h, according to the 2012 universal definition of MI [13] . In clinical studies using cMRI before and after CABG, the incidence of Type 5 MI varies from 20 to 32% [11, 12] . In our study, we found an 8% incidence in Type 5 MI. The decisions of having additional diagnostic imaging procedures in the postoperative period were left to the attending physicians (team of anaesthesiologists, cardiac surgeons and cardiologists). Therefore, the incidence of Type 5 MI in our study most likely reflects a real world clinical scenario.
Limitations
Our study has a number of limitations. First, the number of patients with Type 5 MI is limited. Secondly, our results do not apply to all kind of CABG patients, as we only included nondiabetic patients with two-and three-vessel disease, in whom elective on-pump surgery without concomitant valve replacement or other procedures were performed. The reason for this narrow selection was a wish to limit the number of factors, which per se might influence the serial measurements of cTnI. Thirdly, worldwide, a number of cTnI assays are available and a considerable difference between these exists [14, 15] . For this reason, our results may not be comparable with studies that have used other troponin I assays. Owing to the lack of standardization between different cardiac troponin assays, individual reference ranges should preferably be established for each assay.
Conclusion
A significant rise and fall pattern of serial cTnI measurements was observed in all patients postoperatively. The time from CABG to the peak cTnI value differed in patients with and without Type 5 MI. Based on these results, cTnI measurements can be used to rule out Type 5 MI with a negative predictive value of 0.99. Indeed, the biomarker criteria proposed by the universal definition -including the 2012 redefinition-appear to be of limited value in ruling in a Type 5 MI. For clinical use, we suggest that cTnI should be routinely measured 12 and 24 h following CABG. With the cTnI assay used in this study, we recommend 8000 ng/l (267 times the URL) as the cut-off value at 12 h and 10 000 ng/l (333 times the URL) at 24 h for ruling out the presence of a Type 5 MI.
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